Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Lasers Surg Med ; 47(9): 765-72, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26414998

RESUMO

BACKGROUND AND OBJECTIVES: As the population ages, osteometabolic diseases and osteoporotic fractures emerge, resulting in substantial healthcare resource utilization and impaired quality of life. Many types of mechanical stimulation have the potential of being recognized by bone cells after a mechanical sign is transformed into a biological one (a process called mechanotransduction). The therapeutic ultrasound (TU) is one of several resources capable of promoting bone cell mechanical stimulation. Therefore, the main purpose of present study was to evaluate the effect of TU on the proliferation of pre-osteoblasts using in vitro bioassays. STUDY DESIGN/MATERIALS AND METHODS: We used MC3T3-E1 pre-osteoblast lineage cells kept in Alpha medium. Cells were treated using pulsed mode therapeutic ultrasound, with frequency of 1 MHz, intensity of 0.2 W/cm(2) (SATA), duty cycle of 20%, for 30 minutes. Nifedipine and rapamycin were used to further investigate the role of L-type Ca(2+) channels and mTOR pathway. Intracellular calcium, TGF-ß1, magnesium, and the mRNA levels of osteopontin, osteonectin, NF-κB1, p38α were evaluated. RESULTS: The results show that TU stimulates the growth of MC3T3-E1 cells and decreases the supernatant calcium and magnesium content. Also, it increases intracellular calcium, activates NF-κB1 and mTOR complex via p38α. Moreover, TU promoted a decrease in the TGF-ß1 synthesis, which is a cell growth inhibitor. CONCLUSIONS: Therapeutic ultrasound, with frequency of 1 MHz, intensity of 0.2 W/cm(2) (SATA) and pulsed mode, for 30 minutes, was able to increase the proliferation of preosteoblast-like bone cells. This effect was mediated by a calcium influx, with a consequent activation of the mTOR pathway, through increased NF-κB1 and p38α.


Assuntos
Proliferação de Células/efeitos da radiação , Proteína Quinase 14 Ativada por Mitógeno/fisiologia , NF-kappa B/fisiologia , Osteoblastos/efeitos da radiação , Serina-Treonina Quinases TOR/fisiologia , Terapia por Ultrassom , Células 3T3 , Animais , Técnicas de Cultura de Células , Diferenciação Celular , Camundongos , Osteoblastos/metabolismo , Osteoblastos/patologia
2.
An Acad Bras Cienc ; 87(2 Suppl): 1397-408, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26247152

RESUMO

Several studies have investigated the antinociceptive, immunomodulatory and anti-inflammatory properties of compounds found in the lavender essential oil (LEO), however to date, there is still lack of substantial data. The objective of this study was to assess the antioxidant, anti-inflammatory and antinociceptive effects of lavender essential oil. The 1,1-diphenyl-2-picrylhydrazyl radical decolorization assay was used for antioxidant activity evaluation. The anti-inflammatory activity was tested using two models of acute inflammation: carrageenan-induced pleurisy and croton oil-induced ear edema. The antinociceptive activity was tested using the pain model induced by formalin. LEO has antioxidant activity, which is dose-dependent response. The inflammatory response evoked by carrageenan and by croton oil was reduced through the pre-treatment of animals with LEO. In the pleurisy model, the drug used as positive control, dexamethasone, was more efficacious. However, in the ear swelling, the antiedematogenic effect of the oil was similar to that observed for dexamethasone. In the formalin test, LEO consistently inhibited spontaneous nociception and presented a similar effect to that of tramadol. The results of this study reveal (in vivo) the analgesic and anti-inflammatory activities of LEO and demonstrates its important therapeutic potential.


Assuntos
Analgésicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Antioxidantes/uso terapêutico , Edema/tratamento farmacológico , Óleos Voláteis/uso terapêutico , Dor/tratamento farmacológico , Óleos de Plantas/uso terapêutico , Analgésicos/isolamento & purificação , Animais , Anti-Inflamatórios/isolamento & purificação , Antioxidantes/isolamento & purificação , Carragenina , Óleo de Cróton , Modelos Animais de Doenças , Edema/induzido quimicamente , Feminino , Lavandula , Dor/induzido quimicamente , Medição da Dor , Ratos , Ratos Wistar
3.
Inflamm Res ; 63(9): 719-28, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24888322

RESUMO

OBJECTIVE AND DESIGN: Mesenchymal stem cells (MSCs) are potent modulators of immune responses. Sepsis is the association of a systemic inflammatory response with an infection. The aim of this study was to test the ability of MSCs derived from adipose tissue, which have immunomodulatory effects, and to inhibit the septic process in an experimental model of mice. METHODS: Three experimental groups (male C57BL/6 mice) were formed for the test: control group, untreated septic group and septic group treated with MSCs (1 × 10(6) cells/animal). RESULTS: In the control group, there were no deaths; in the untreated septic group, the mortality rate was 100 % within 26 h; in the septic group treated with MSCs, the mortality rate reached 40 % within 26 h. The group treated with MSCs was able to reduce the markers of tissue damage in the liver and pancreas. The treated group had a reduction of inflammatory markers. Furthermore, the MSCs-treated group was able to inhibit the increase of apoptosis in splenocytes observed in the untreated septic group. CONCLUSIONS: Our data showed that MSCs ameliorated the immune response with decrease of inflammatory cytokines and increase anti-inflammatory IL-10; moreover, inhibited splenocytes apoptosis and, consequently, inhibited tissue damage during sepsis.


Assuntos
Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/imunologia , Sepse/terapia , Baço/citologia , Alanina Transaminase/sangue , Amilases/sangue , Animais , Apoptose , Aspartato Aminotransferases/sangue , Glicemia/análise , Células Cultivadas , Citocinas/sangue , Modelos Animais de Doenças , Masculino , Potencial da Membrana Mitocondrial , Camundongos Endogâmicos C57BL , Sepse/sangue , Sepse/imunologia , Fator de Crescimento Transformador beta1/sangue
4.
Molecules ; 17(1): 1113-23, 2012 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-22269829

RESUMO

Baccharis trimera is a plant popularly used as a tea and to treat gastrointestinal diseases and inflammatory processes as well. The total phenolic content was determined and the antioxidant and anti-inflammatory activities of six extracts (dichloromethane, ethyl acetate, butanol, aqueous, saponin and phenolic) from B. trimera were evaluated. Using carrageenan-induced pleurisy as a model of acute inflammation, the phenolic extract at 15 mg/kg decreased significantly the analyzed parameters when compared to the carrageenan group ( p < 0.05), thus showing potential anti-inflammatory activity. The total phenolic content and antioxidant activity were evaluated by the Folin-Ciocalteau and DPPH methods, respectively. Phenolic and ethyl acetate extracts presented higher antioxidant activity ( p < 0.05) than ascorbic acid. The phenolic extract also showed the highest antioxidant potential in relation to the other extracts, thus suggesting that the antioxidant and anti-inflammatory activities were due to the presence of phenolic compounds.


Assuntos
Anti-Inflamatórios/farmacologia , Antioxidantes/farmacologia , Baccharis/química , Fenóis/química , Extratos Vegetais/farmacologia , Animais , Ácido Ascórbico/metabolismo , Compostos de Bifenilo/metabolismo , Carragenina , Feminino , Concentração Inibidora 50 , Óxido Nítrico/metabolismo , Picratos/metabolismo , Folhas de Planta/química , Pleurisia/patologia , Ratos , Ratos Wistar
5.
Inflammopharmacology ; 19(3): 145-53, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20981574

RESUMO

RDV-8 [C(18)H(22)N(2)O(2)S (ethyl 1-butyl-6-methyl-2-phenyl-4-thioxo-1,4-dihydropyrimidine-5-carboxylate)] is derived from the 4-thioxopyrimidine, and presents important clinical effects. The present study explored the RDV-8 effects in the proliferation of human peripheral blood mononuclear cells (PBMCs), as well as in a pleurisy-induced rat model. PBMCs were directly plated in four different RDV-8 concentrations (0.0125, 0.025, 0.05 and 0.1 mg/mL). RDV-8 decreased cell proliferation and monocyte chemotactic protein 1 synthesis. The interleukin 1 levels and the cytotoxic effect were not significantly affected by RDV-8 treatment. In the carrageenan-induced pleurisy model, the RDV-8 (3 mg/kg) treatment induced a significant reduction in the exudate volume, in the polymorphonuclear leukocyte migration and in the pleural exudate NO levels. The results indicate that RDV-8 may have an immunomodulatory effect, as well as anti-inflammatory actions suggesting that it could represent a new strategy in the inflammatory response modulation.


Assuntos
Anti-Inflamatórios/farmacologia , Fatores Imunológicos/farmacologia , Pleurisia/tratamento farmacológico , Pirimidinas/farmacologia , Tionas/farmacologia , Animais , Anti-Inflamatórios/administração & dosagem , Carragenina , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Quimiocina CCL2/biossíntese , Quimiocina CCL2/efeitos dos fármacos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Feminino , Humanos , Fatores Imunológicos/administração & dosagem , Leucócitos Mononucleares/efeitos dos fármacos , Leucócitos Mononucleares/metabolismo , Neutrófilos/efeitos dos fármacos , Neutrófilos/metabolismo , Óxido Nítrico/metabolismo , Pleurisia/fisiopatologia , Pirimidinas/administração & dosagem , Ratos , Ratos Wistar , Tionas/administração & dosagem
6.
J Pharm Pharmacol ; 60(4): 473-8, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18380920

RESUMO

Inflammation is a pivotal component of a variety of diseases, such as atherosclerosis and tumour progression. Various naturally occurring phytochemicals exhibit anti-inflammatory activity and are considered to be potential drug candidates against inflammation-related pathological processes. Capsicum baccatum L. var. pendulum (Willd.) Eshbaugh (Solanaceae) is the most consumed species in Brazil, and its compounds, such as capsaicinoids, have been found to inhibit the inflammatory process. However, the anti-inflammatory effects of C. baccatum have not been characterized. Thus, this study was designed to evaluate the effects of C. baccatum juice in animal models of acute inflammation induced by carrageenan and immune inflammation induced by methylated bovine serum albumin. Pretreatment (30 min) of rats with pepper juice (0.25-2.0 g kg(-1)) significantly decreased leucocyte and neutrophil migration, exudate volume and protein and LDH concentration in pleural exudates of a pleurisy model. This juice also inhibited neutrophil migration and reduced the vascular permeability on carrageenan-induced peritonitis in mice. C. baccatum juice also reduced neutrophil recruitment and exudate levels of pro-inflammatory cytokines TNF-alpha and IL-1beta in mouse inflammatory immune peritonitis. Furthermore, we demonstrated that the main constituent of C. baccatum juice, as extracted with chloroform, is capsaicin. In agreement with this, capsaicin was able to inhibit the neutrophil migration towards the inflammatory focus. To our knowledge, this is the first demonstration of the anti-inflammatory effect of C. baccatum juice and our data suggest that this effect may be induced by capsaicin. Moreover, the anti-inflammatory effect induced by red pepper may be by inhibition of pro-inflammatory cytokine production at the inflammatory site.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Capsaicina/uso terapêutico , Capsicum/química , Preparações de Plantas/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/isolamento & purificação , Permeabilidade Capilar , Capsaicina/química , Capsaicina/isolamento & purificação , Carragenina , Movimento Celular/efeitos dos fármacos , Edema/induzido quimicamente , Edema/tratamento farmacológico , Exsudatos e Transudatos/efeitos dos fármacos , Inflamação/tratamento farmacológico , Inflamação/imunologia , Interleucina-1beta/análise , L-Lactato Desidrogenase/análise , Leucócitos/efeitos dos fármacos , Leucócitos/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Peritonite/induzido quimicamente , Peritonite/tratamento farmacológico , Fitoterapia , Preparações de Plantas/química , Preparações de Plantas/isolamento & purificação , Pleurisia/induzido quimicamente , Pleurisia/tratamento farmacológico , Ratos , Ratos Wistar , Soroalbumina Bovina/imunologia , Fator de Necrose Tumoral alfa/análise
7.
Lasers Surg Med ; 40(7): 500-8, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18727002

RESUMO

BACKGROUND AND OBJECTIVE: In the classic model of pleurisy there is little evidence about the anti-inflammatory effects of low-level laser therapy (LLLT) as well the dosage characteristics, such as wavelength, total energy, number and pattern of treatment. In this study we investigated the potential effects of LLLT on modulating the pro-inflammatory and anti-inflammatory mediators of acute inflammation in a rat pleurisy model. STUDY DESIGN/MATERIALS AND METHODS: A sample of 48 female Wistar rats were divided into control and experiential groups. An inflammation was induced by carrageenan (0.2 ml) injected into the pleural cavity. At 1, 2, and 3 hours after induction a continuous wave (20 mW) diode laser of the InGaAlP (660 nm) type was used in the four laser groups with different doses and treatment patterns. One group received a single dose of 2.1 J and the other three groups received a total energy of 0.9, 2.1, and 4.2 J. Four hours later the exudate volume, total and differential leukocytes, protein concentration, NO, IL-6, IL-10, TNF-alpha, and MCP-1 were measured from the aspirated liquid. RESULTS: All the treatment patterns and quantity of energy studied show significant reduction of the exudate volume (P<0.05). Using energy of 0.9 J only NO, IL-6, MCP-1 and IL-10 are significantly reduced (P<0.05). On the other hand, higher energies (2.1 and 4.2 J) significantly reduce all variables independently of the treatment pattern. The neutrophil migration has a straight correlation with the TNF-alpha (r = 0.551) and NO (r = 0.549) concentration. CONCLUSIONS: LLLT-660 nm induced an anti-inflammatory effect characterized by inhibition of either total or differential leukocyte influx, exudation, total protein, NO, IL-6, MCP-1, IL-10, and TNF-alpha, in a dose-dependent manner. Under these conditions, laser treatment with 2.1 J was more effective than 0.9 and 4.2 J.


Assuntos
Terapia com Luz de Baixa Intensidade , Pleurisia/radioterapia , Animais , Carragenina/administração & dosagem , Feminino , Inflamação/complicações , Inflamação/radioterapia , Pleurisia/induzido quimicamente , Pleurisia/complicações , Ratos , Ratos Wistar
8.
Ultrasonics ; 84: 290-295, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29182945

RESUMO

The present study aimed to evaluate the effect of low-intensity pulsed ultrasound (LIPUS) on pre-osteoblast mineralization using in vitro bioassays. Pre-osteoblastic MC3T3-E1 cells were exposed to LIPUS at 1 MHz frequency, 0.2 W/cm2 intensity and 20% duty cycle for 30 min. The analyses were carried out up to 336 h (14 days) after exposure. The concentration of collagen, phosphate, alkaline phosphatase, calcium and transforming growth factor beta 1 (TGF-ß1) in cell supernatant and the presence of calcium deposits in the cells were analyzed. Our results showed that LIPUS promotes mineralized nodules formation. Collagen, phosphate, and calcium levels were decreased in cell supernatant at 192 h after LIPUS exposure. However, alkaline phosphatase and TGF-ß1 concentrations remained unchanged. Therapeutic pulsed ultrasound is capable of stimulating differentiation and mineralization of pre-osteoblastic MC3T3-E1 cells by calcium and phosphate uptake with consequent hydroxyapatite formation.


Assuntos
Cálcio/metabolismo , Colágeno/metabolismo , Durapatita/metabolismo , Osteoblastos/citologia , Osteoblastos/metabolismo , Fosfatos/metabolismo , Ondas Ultrassônicas , Células 3T3 , Fosfatase Alcalina/metabolismo , Animais , Diferenciação Celular , Linhagem Celular , Técnicas In Vitro , Camundongos , Fator de Crescimento Transformador beta/metabolismo
9.
J Cosmet Dermatol ; 15(4): 393-398, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27090205

RESUMO

BACKGROUND: Striae distensae are linear atrophic dermal scars with associated epidermal atrophy. This recurrent skin disorder causes a significant cosmetic and psychologic concern and remains a therapeutic challenge, especially when they are mature and hypopigmented (striae alba). AIMS: In this prospective single-center study, we evaluated the efficacy, safety, and patient's satisfaction of galvanopuncture for the treatment of striae alba. PATIENTS/METHODS: Thirty-two female subjects with striae alba present on the buttocks were treated with galvanopuncture once a week over a period of 10 weeks. Photographs and a percentage category scale were used to assess striae improvement and patient's satisfaction. Biochemical analyses were performed to assess possible systemic inflammatory effects or oxidative stress induction by the treatment. RESULTS: All patients achieved a substantial increase in clinical improvement in their striae within 10 treatment sessions. Galvanopuncture did not induce any inflammatory effect; however, it reduced oxidative injury. CONCLUSION: The use of galvanopuncture for the treatment of striae alba demonstrated a significant improvement in the lesions with visible results. This study supports the high degree of patient's satisfaction and demonstrate the safe and effective use of galvanopuncture in the treatment of striae alba on several skin types.


Assuntos
Terapia por Estimulação Elétrica/métodos , Inflamação/sangue , Estresse Oxidativo , Estrias de Distensão/terapia , Adulto , Proteína C-Reativa/metabolismo , HDL-Colesterol/sangue , LDL-Colesterol/metabolismo , Terapia por Estimulação Elétrica/efeitos adversos , Terapia por Estimulação Elétrica/instrumentação , Feminino , Humanos , Inflamação/diagnóstico , Inflamação/etiologia , Lipoproteínas LDL/sangue , Agulhas , Óxido Nítrico/sangue , Satisfação do Paciente , Projetos Piloto , Estudos Prospectivos , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Fator de Necrose Tumoral alfa/sangue , Adulto Jovem
10.
Physiol Behav ; 151: 516-24, 2015 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-26314499

RESUMO

The present study aimed to evaluate the long-term effects of neonatal inflammation on the inflammatory and oxidative profile during experimental sepsis in adult life. Neonatal Balb/c mice received different treatments on day 10: LPS i.p. injection (100g/kg) (nLPS) or saline i.p. injection (nSal). As adults, fear/anxiety behavior was evaluated in the elevated plus maze. The following week, saline solution or LPS was administered and, after 12h, serum (inflammatory cytokines), liver (mitochondrial complexes and oxidative stress) and adrenal gland samples (angiotensin II type 1 and 2 receptors) were collected. There was an increase in the fear/anxiety behavior in the nLPS group. Neonatal administration of LPS increased the mRNA expression of the AT1 receptor and decreased the mRNA expression of the AT2 receptor in the adrenal glands of males. The complexes II and II-III increased in the nLPS saline male group when compared to control. The LPS administration in adult females, regardless of the neonatal treatment, induced a decrease of the glutathione enzyme activity. There were no differences in the inflammatory cytokines. The results showed that neonatal inflammation influenced mitochondrial respiratory chain metabolism and angiotensin II receptors in a sex-dependent manner. Balb/c mice fear and anxiety behaviors in adulthood were programmed by early life inflammatory stress.


Assuntos
Inflamação/fisiopatologia , Sepse/fisiopatologia , Glândulas Suprarrenais/fisiopatologia , Animais , Animais Recém-Nascidos , Ansiedade , Citocinas/sangue , Modelos Animais de Doenças , Medo , Feminino , Lipopolissacarídeos , Fígado/fisiopatologia , Masculino , Camundongos Endogâmicos BALB C , Estresse Oxidativo , RNA Mensageiro/metabolismo , Receptores de Angiotensina/metabolismo , Caracteres Sexuais
11.
Int Immunopharmacol ; 3(2): 267-72, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12586607

RESUMO

Sepsis remains an important and life-threatening problem, and is the most common cause of death in the intensive care unit. One promising therapeutic candidate for protection against injury in sepsis is fructose-1,6-bisphosphate (FBP), a high-energy glycolytic pathway intermediate. The objective of the study was to establish a role for FBP on the immune system, especially in lymphocyte proliferation. Peripheral blood mononuclear cells (PBMCs) were isolated from the blood of healthy humans by gradient centrifugation. T-lymphocytes were stimulated for 96 h with phytohemagglutinin (PHA) and varying concentration of FBP. Fructose-1,6-bisphosphate at concentrations between 1.2 and 10 mM decreased proliferation of T-lymphocytes and reduced the viability only at concentrations 5.0 and 10 mM. The levels of soluble IL-2 receptor were reduced at FBP concentrations between 1.2 and 10 mM. In conclusion, this study demonstrates that FBP has important effect on immunomodulatory and this result can be correlated with the protection against injury in sepsis.


Assuntos
Frutosedifosfatos/farmacologia , Imunossupressores/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Linfócitos T/efeitos dos fármacos , Cálcio/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Humanos , Receptores de Interleucina-2/análise , Linfócitos T/imunologia
12.
Toxicol Lett ; 143(1): 73-81, 2003 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-12697383

RESUMO

Fructose-1,6-bisphosphate (FBP) is a bisphosphorilated sugar with a protective action against events that lead to cellular damage. The toxicity of the drug was assessed when administered intravenously in Wistar rats in doses of between 250 and 4000 mg/kg. Ionic calcium, total calcium, inorganic serum phosphate and the electrocardiographic profile of these animals were assessed. The lethal dose (LD(50)) was established by means of PROBIT processing. There was no reduction in the levels of total calcium, with the administration of increased doses of FBP, although there was a significant reduction in the levels of ionic calcium in those groups that received 250 mg/kg and over. The serum phosphate showed a significant statistical increase in those groups that received 750 mg/kg and over. The LD(50) obtained in 24 h was 1068 mg/kg. Though it was not possible to elucidate the toxic mechanism of FBP, the electrocardiogram (ECG) showed that all the rats died of cardiac arrest.


Assuntos
Frutosedifosfatos/toxicidade , Animais , Cálcio/sangue , Eletrocardiografia/efeitos dos fármacos , Frutosedifosfatos/administração & dosagem , Injeções Intravenosas , Dose Letal Mediana , Masculino , Fosfatos/sangue , Ratos , Ratos Wistar
13.
Inflammation ; 34(1): 67-71, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20419391

RESUMO

Cisplatin is one of the most active cytotoxic agents in the treatment of cancer, but its clinical use is frequently limited by nephrotoxicity. The study presented here attempted to evaluate the effect of fructose-1,6-bisphosphate in the cisplatin-induced nephrotoxicity in rats. The drugs were administered intraperitoneally as a single dose: sodium chloride 0.9%, cisplatin (6 mg/kg), fructose-1,6-bisphosphate (500 mg/kg), and cisplatin plus fructose-1,6-bisphosphate (6 and 500 mg/kg, respectively). The use of cisplatin resulted in significant elevation of serum creatinine and urea. The group that received cisplatin plus fructose-1,6-bisphosphate presented a significantly lower level of creatinine and urea compared to the cisplatin group. Acute tubular necrosis was demonstrated in the animals that received cisplatin and a less severe one in the cisplatin plus fructose-1,6-bisphosphate group. Fructose-1,6-bisphosphate has a protective effect over renal function and renal parenchyma in a rat experimental model of cisplatin-induced nephrotoxicity. The anti-inflammatory effect of fructose-1,6-bisphosphate confirms its protective effect in cases of cellular injury.


Assuntos
Cisplatino/toxicidade , Frutosedifosfatos/farmacologia , Necrose Tubular Aguda/induzido quimicamente , Rim/efeitos dos fármacos , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/prevenção & controle , Animais , Creatinina/sangue , Citoproteção , Frutosedifosfatos/administração & dosagem , Rim/patologia , Necrose Tubular Aguda/prevenção & controle , Masculino , Necrose , Óxido Nítrico/sangue , Óxido Nítrico Sintase/genética , Ratos , Ratos Wistar , Ureia/sangue , Redução de Peso/efeitos dos fármacos
14.
Inflammation ; 34(6): 539-50, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20882329

RESUMO

Sepsis is a syndrome caused by uncontrolled systemic inflammatory response of the individual, which represents a serious epidemiological problem worldwide. The aim of this study was to investigate the effect of N-acetylcysteine (NAC) and fructose-1,6-bisphosphate (FBP) in the treatment of experimental sepsis. We used rats that were divided into five experimental groups: normal control (not induced), septic control (induced using a capsule with non sterile fecal content and Escherichia coli), treated with FBP (500 mg/kg i.p.), treated with NAC (150 mg/kg i.p.), and treated with the combination of FBP with NAC. In the group treated with NAC, 16.68% of the mice survived, the FBP reduced the mortality of mice during the acute stage of the disease and increased the animals' survival time in 33.34%, and the combination of drugs had no effect. Our results show that NAC prevented the mortality of animals after septic induction. These data confirm the validity of the use of NAC in the treatment of sepsis. Our data also show that the synergistic action with FBP does not improve the picture.


Assuntos
Acetilcisteína/uso terapêutico , Frutose-Bifosfatase/uso terapêutico , Sepse/tratamento farmacológico , Acetilcisteína/farmacologia , Animais , Sinergismo Farmacológico , Quimioterapia Combinada , Frutose-Bifosfatase/farmacologia , Ratos , Sepse/mortalidade , Taxa de Sobrevida , Resultado do Tratamento
15.
Int Immunopharmacol ; 11(6): 706-11, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21296699

RESUMO

Acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) are common syndromes that affect both clinical and surgical patients. This study describes the effects of a potent and specific N-methyl-d-aspartate receptor antagonist (MK-801) against oxidative stress in acute lung injury induced by intratracheal lipopolysaccharide (LPS) injection. This study was performed using male Wistar rats weighing 200-250g. Rats were randomly divided into four groups: control with isotonic saline instillation (n=6); LPS (100µg/100g of body weight) treated with saline (n=6); LPS treated with MK-801 (0.3mg/kg, intraperitoneally; n=6); LPS treated with MK-801 (0.3mg/kg, intratracheally; n=6). Twelve hours after the LPS instillation, rats were anesthetized and a bronchoalveolar lavage (BAL) was performed in order to determine the alveolar-capillary membrane alterations and the inflammatory infiltrate level. Blood and lung samples were isolated and assayed for oxidative stress variables and histopathologic analysis. The use of MK-801 decreased bronchoalveolar lavage fluid protein, LDH activity and inflammatory cells. Indeed, the treatment with MK-801 significantly attenuated lung oxidative damage and histopathologic alterations after LPS instillation. Our data provide the first experimental demonstration that MK-801 decreases oxidative stress and limits inflammatory response and alveolar disarray in lipopolysaccharide-induced acute lung injury.


Assuntos
Lesão Pulmonar Aguda/tratamento farmacológico , Maleato de Dizocilpina , Pulmão/efeitos dos fármacos , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Síndrome do Desconforto Respiratório/tratamento farmacológico , Lesão Pulmonar Aguda/induzido quimicamente , Lesão Pulmonar Aguda/imunologia , Lesão Pulmonar Aguda/fisiopatologia , Animais , Lavagem Broncoalveolar , Contagem de Células , Movimento Celular/efeitos dos fármacos , Citoproteção , Modelos Animais de Doenças , Maleato de Dizocilpina/administração & dosagem , Maleato de Dizocilpina/farmacologia , Humanos , L-Lactato Desidrogenase/metabolismo , Lipopolissacarídeos/administração & dosagem , Pulmão/metabolismo , Pulmão/patologia , Masculino , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar , Síndrome do Desconforto Respiratório/imunologia
16.
J. bras. patol. med. lab ; 51(6): 383-388, Nov.-Dec. 2015. graf
Artigo em Inglês | LILACS | ID: lil-767694

RESUMO

ABSTRACT Introduction: Literature reports addressing ischemia modified albumin (IMA) as a good marker for the early diagnosis of myocardial ischemia through albumin cobalt binding (ACB) test, that is before myocardial infarction (MI) occurs. Objective: To evaluate the IMA plasmatic levels in infarcted patients, in order to verify its potential as an early marker for early diagnosis of MI, investigate its correlation with existing cardiac biomarkers such as total creatine kinase (CK) and creatine kinase-MB fraction (CK-MB), as well as to assess the correlation between IMA and oxidative stress. Methods: The sample was divided into two groups according to serum troponin I (TnI) results; one group of infarcted patients (with MI) (TnI levels higher than 0.05 ng/ml), and the other group of non-infarcted patients (without MI) (TnI levels lower than 0.05 ng/ml). The results of total CK, CK-MB, thiobarbituric acid reactive substances (TBARS), and IMA were analyzed in both groups. Results: Regarding the existing cardiac markers, there was a significant increase of total CK and CK-MB levels in With MI group. In relation to the oxidative stress parameter, a significant increase was observed in with MI group compared to without MI group. However, IMA showed no significant difference between the groups; and also there was no significant correlation between IMA and the cardiac markers. There was no correlation between IMA and TBARS. Conclusion: Our results suggest that IMA cannot be used alone for the diagnosis of MI.


RESUMO Introdução: Relatos na literatura abordam a albumina modificada isquêmica (AMI) como um bom marcador precoce para o diagnóstico de isquemia miocárdica por meio do albumin cobalt binding (ACB) test, ou seja, antes do infarto do miocárdico (IM). Objetivo: Avaliar os níveis plasmáticos de AMI em pacientes infartados a fim de verificar o seu potencial como marcador precoce para o diagnóstico antecipado do IM, investigar sua correlação com os biomarcadores cardíacos já existentes, como creatinaquinase (CK) total e creatinaquinase fração MB (CK-MB), além de avaliar a correlação de AMI com o estresse oxidativo. Métodos: Foram separados dois grupos de acordo com resultados séricos da troponina I (TnI), um com pacientes infartados (TnI superior a 0,05 ng/ml) e outro com pacientes não infartados (TnI inferior a 0,05 ng/ml). Foram analisados os resultados de CK total, CK-MB, substâncias reativas ao ácido tiobarbitúrico (TBARS) e AMI em ambos os grupos. Resultados: Em relação aos marcadores cardíacos existentes, houve aumento significativo de CK total e CK-MB no grupo dos infartados; já em relação ao parâmetro de estresse oxidativo, foi observado aumento significativo no grupo dos infartados quando comparado com o dos não infartados. Contudo, a AMI não apresentou diferença significativa entre os grupos; também não houve correlação relevante entre AMI e os marcadores cardíacos, bem como não foi observada correlação de AMI com TBARS. Conclusão: Nossos resultados sugerem que AMI não pode ser utilizada isoladamente como diagnóstico de IM.

17.
Inflammation ; 33(3): 173-9, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20020191

RESUMO

The following study aimed to evaluate, in vitro and in vivo, the anti-inflammatory effect of Ulomoides dermestoides, a beetle commonly used as a remedy for a variety of diseases including respiratory disorders and asthma. We used an acute inflammation model of injury, injection of carrageenan into the pleural cavity of rats. The rats were treated intraperitoneally with the aqueous extract of U. dermestoides 8 and 16 mg/kg. The exudate volume, protein concentration, polymorphonuclear leukocytes (PMNs) and total leukocyte were measured. The peripheral blood mononuclear cells (PBMCs) were isolated from the blood of healthy subjects and we investigated the immunomodulatory and cytotoxic effect of aqueous extract of U. dermestoides. In conclusion, in vitro we observed a non-cytotoxic effect and antiproliferative activity on the dose of 12.5 mg/dL. In vivo, this paper clarifies the great clinical relevance of the aqueous extract of U. dermestoides in elucidating its role as an anti-inflammatory agent.


Assuntos
Anti-Inflamatórios/farmacologia , Besouros , Proteínas de Insetos/farmacologia , Pleurisia/tratamento farmacológico , Pleurisia/imunologia , Animais , Brasil , Carragenina/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/imunologia , Células Cultivadas , Misturas Complexas/farmacologia , Relação Dose-Resposta a Droga , Exsudatos e Transudatos/imunologia , Feminino , Proteínas de Insetos/imunologia , Medicina Tradicional , Pleurisia/induzido quimicamente , Ratos , Ratos Wistar , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia
18.
Clin Chem Lab Med ; 47(4): 458-63, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19275502

RESUMO

BACKGROUND: Carbamazepine is a first-choice antiepileptic drug for the treatment of simple and complex partial seizures. The use of an established therapeutic range for carbamazepine concentration is limited by the presence of carbamazepine-10,11-epoxide, its active metabolite that significantly contributes to the efficacy and toxicity and is not routinely measured and accounted for. This article describes the development of a HPLC method for determination of carbamazepine and carbamazepine-10,11-epoxide in serum, and compares it with chemiluminescence immunoassay to evaluate the importance of considering the active metabolite in therapeutic strategies. METHODS: The procedure involves protein precipitation, separation on a reverse-phase column and ultraviolet detection. The analytical procedure proved to be sensitive, selective, precise, accurate and linear (regression coefficients >0.999) in the range of 0.5-25.0 microg/mL and 0.1-10.0 microg/mL for quantification of carbamazepine and carbamazepine-10,11-epoxide, respectively. For the comparison between methods, serum samples of 75 patients using the medication were evaluated. RESULTS: The Pearson correlation coefficient showed that the carbamazepine concentrations measured by HPLC are significantly higher than those obtained by immunoassay (mean difference of 1.07 microg/mL, 95% limits of agreement from -0.65 to 2.80 microg/mL). CONCLUSIONS: This difference may be decisive for the therapy. In some cases, this may affect the individual dosage adjustment and subsequent treatment.


Assuntos
Carbamazepina/análogos & derivados , Carbamazepina/análise , Cromatografia Líquida de Alta Pressão/métodos , Imunoensaio/métodos , Medições Luminescentes/métodos , Humanos , Modelos Lineares , Sensibilidade e Especificidade
19.
Rev. bras. oftalmol ; 73(5): 282-286, Sep-Oct/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-741905

RESUMO

Objetive: The purpose of this study is to map the serological profile of candidates to corneal donation at Irmandade Santa Casa de Misericórdia de Porto Alegre, identifying the percentage of disposal by serology and the marker involved. Methods: There have been analised – retrospectively – the results of serology of all corneal donors, made between the period of 1st january 2006 and 31st december 2012. Data analised were related to age, gender and the results of serology pertinent to viral markers (HBsAg, anti-HBc, anti-HCV and anti-HIV), these, determined by immunosorbent tests (ELISA). Results: In the period of the study, there were 2476 corneal donors at the institution, with a major incidence on the male gender, on an average of 58.7 years old. 23% of retention because of serological unfitness was also identified, that is, 570 samples were non-negative to any of the used tests. The marker anti- HBc was the most prevalent on the studied population, followed by the Hepatitis C virus (HCV) and by the Human Immunodeficiency Virus (HIV). Conclusion: From the data found through this study, it is essential to have the participation of an efficient service on the serological evaluation of the candidates to corneal donation, once the security of the receptor must be taken into consideration in a population of donors with 23% of unfitness prevalence, in which the most prevalent marker is the one of Hepatits B. .


Objetivo: O intento deste desígnio é mapear o perfil sorológico dos candidatos a doação de córneas na Irmandade Santa Casa de Misericórdia de Porto Alegre, identificando o percentual de descarte por sorologia e o marcador envolvido. Métodos: Foram analisados – retrospectivamente – os resultados da sorologia de todos os doadores de córneas compreendidos entre 01 de janeiro de 2006 a 31 de dezembro de 2012. Foram avaliados os dados de idade, sexo e os resultados da sorologia pertinentes aos marcadores virais (HBsAg, anti-HBc, anti-HCV e anti-HIV) determinados por testes imunoenzimáticos (ELISA). Resultados: No período coberto pelo estudo, houve 2476 doadores de córneas na instituição, com maior ocorrência do sexo masculino e média de 58,7 anos de idade. Foram verificados 23,0% de retenção por inaptidão sorológica, ou seja, 570 amostras mostraram-se não-negativas para qualquer dos testes empregados. O marcador anti-HBc foi o mais prevalente na população aferida, seguido pelo vírus da hepatite C (HCV) e pelo vírus da imunodeficiência humana (HIV). Conclusão: Diante dos dados encontrados por este estudo, torna-se decisiva a participação de um serviço eficaz no tangente à avaliação sorológica dos candidatos à doação de córnea, uma vez que a segurança do receptor deve ser considerada numa população de doadores com prevalência de retenção por inaptidão sorológica de 23,0%, donde o marcador mais prevalente é o de hepatite B. .


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Doadores de Tecidos/estatística & dados numéricos , Biomarcadores , Transplante de Córnea , Córnea/imunologia , Córnea/virologia , Manejo de Espécimes/métodos , Obtenção de Tecidos e Órgãos/métodos , Obtenção de Tecidos e Órgãos/estatística & dados numéricos , Viroses/diagnóstico , Testes Sorológicos/métodos , Anticorpos Anti-HIV/sangue , Centrifugação , Técnicas Imunoenzimáticas/métodos , Anticorpos Anti-Hepatite C/sangue , Coleta de Tecidos e Órgãos/estatística & dados numéricos , Seleção do Doador/normas , Seleção do Doador/estatística & dados numéricos , Anticorpos Anti-Hepatite B/sangue , Antígenos do Núcleo do Vírus da Hepatite B/sangue , Antígenos de Superfície da Hepatite B/sangue
20.
Inflammation ; 32(6): 419-25, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19756999

RESUMO

Baccharis trimera is a widespread South American plant known as "carqueja". Medicinal teas prepared from the aerial parts of this plant are used in folk medicine in cases of liver diseases and inflammatory processes. We evaluated the effects of aqueous extract of B. trimera in the experimental inflammatory model of carrageenan-induced pleurisy in rat. The injection of carrageenan into the pleural cavity induces an influx of cells and fluid accumulation with a large number of polymorphonuclear leukocytes and increase of protein levels. The inflammation parameters were attenuated when B. trimera (400 and 800 mg/kg, i.p.) was administrated 30 min before the carrageenan. The immunomodulatory effects were evaluated in vitro on human peripheral blood mononuclear cells. The extract in concentration of 25, 50 and 100 mg/mL presented inhibited the T-lymphocytes proliferation stimulated by phytohemagglutinin, but these extract concentrations also presented cytotoxic effect. These results showed that the aqueous extract of B. trimera has anti-inflammatory effect.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Baccharis , Fatores Imunológicos/uso terapêutico , Ativação Linfocitária/imunologia , Extratos Vegetais/uso terapêutico , Pleurisia/tratamento farmacológico , Pleurisia/patologia , Linfócitos T/imunologia , Animais , Anti-Inflamatórios não Esteroides/isolamento & purificação , Anti-Inflamatórios não Esteroides/farmacologia , Baccharis/imunologia , Carragenina/toxicidade , Proliferação de Células/efeitos dos fármacos , Feminino , Humanos , Fatores Imunológicos/isolamento & purificação , Fatores Imunológicos/farmacologia , Fitoterapia/métodos , Componentes Aéreos da Planta , Extratos Vegetais/isolamento & purificação , Pleurisia/microbiologia , Ratos , Ratos Wistar , Linfócitos T/metabolismo , Água
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA